A Study of Simmitinib Plus SG001 in Advanced Solid Tumors
A Study of Simmitinib Plus SG001 in Advanced Solid Tumors
Not yet recruiting · NCT06132217 · Registry updated 2023-11-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Simmitinib Plus SG001 in Advanced Solid Tumors | Advanced Solid Tumor | Not yet recruiting | Phase 1 / Phase 2 | 2023-11-15 | NCT06132217 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Runshi Pharmaceutical Technology Co., Ltd | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing | China | 1 |